일봉 히스토리컬 데이터와 계정별 기본 설정
공시·실적·리서치·기관 변화를 시간 역순으로 정리
신규 편입 · 포트폴리오 비중 0.08%
신규 편입 · 포트폴리오 비중 0.00%
컨센서스 vs 실제, 그리고 매출 추이
투자의견·목표주가 변경
DB 우선 · Google News · Yahoo Finance 영문 기사
Incyte Gears Up to Report Q2 Earnings: Is a Beat Around the Corner?
Influential Women Highlights Andrea R. Webster, RP: Associate Director Of Legal Innovation & Operations At Novartis - EIN Presswire
Influential Women Highlights Andrea R. Webster, RP: Associate Director Of Legal Innovation & Operations At Novartis EIN Presswire
Is Novartis's Kidney Portfolio a Game Changer After ERA 2026 Data - Kavout | AI
Is Novartis's Kidney Portfolio a Game Changer After ERA 2026 Data Kavout | AI
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next - Novartis
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next Novartis
Revenue Beat: Novartis AG Beat Analyst Estimates By 5.7% - simplywall.st
Revenue Beat: Novartis AG Beat Analyst Estimates By 5.7% simplywall.st
South Korea lands $95.67m Novartis deal for radioligand therapy - Healthcare Asia Magazine
South Korea lands $95.67m Novartis deal for radioligand therapy Healthcare Asia Magazine
표시할 실적 데이터가 없습니다.
표시할 리서치 액션이 없습니다.
가격 데이터
| # | 기관 | 운용 형태 | 보유 주식 | 평가액 | 비중 | 변화율 | 포지션 |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 283,837 | $43.36M | 0.08% | — | 신규 편입 |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 27,528 | $4.2M | 0.00% | — | 신규 편입 |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 29,928 | $4.13M | 0.01% | — | 신규 편입 |